Tibet Weixinkang Medicine Co., Ltd.

XSSC:603676 Stock Report

Market Cap: CN¥4.6b

Tibet Weixinkang Medicine Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yong Zhang

Chief executive officer

CN¥3.0m

Total compensation

CEO salary percentagen/a
CEO tenure9yrs
CEO ownership20.5%
Management average tenure6yrs
Board average tenure4.5yrs

Recent management updates

Recent updates


CEO

Yong Zhang (52 yo)

9yrs

Tenure

CN¥3,000,000

Compensation

Mr. Yong Zhang is Chairman of the Board & GM of Tibet Weixinkang Medicine Co., Ltd. from December 02, 2015. He joined the Tibet Weixinkang Medicine Co., Ltd.in 2015. He has NULL from ShenYang Pharmaceutic...


Leadership Team

NamePositionTenureCompensationOwnership
Yong Zhang
Chairman of the Board & GM9yrsCN¥3.00m20.54%
CN¥ 939.6m
Feng Liu
Vice Chairman & Deputy GM9yrsCN¥1.40m0.88%
CN¥ 40.1m
Shigong Chen
Deputy GM & Director6yrsCN¥1.10m0.12%
CN¥ 5.3m
Yanxia Zheng
Financial Director5.3yrsCN¥700.00k0.069%
CN¥ 3.2m
Liqun Yao
Accounting Supervisorno datano datano data
Haibo Yu
Board Secretary3.5yrsCN¥900.00k0.069%
CN¥ 3.2m
Xiaobing Zhou
Deputy General Manager4.2yrsCN¥940.00k0.10%
CN¥ 4.7m
Zizhong Weng
Deputy General Manager9yrsCN¥1.27m0.078%
CN¥ 3.5m

6.0yrs

Average Tenure

51yo

Average Age

Experienced Management: 603676's management team is seasoned and experienced (6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yong Zhang
Chairman of the Board & GM9yrsCN¥3.00m20.54%
CN¥ 939.6m
Feng Liu
Vice Chairman & Deputy GM9yrsCN¥1.40m0.88%
CN¥ 40.1m
Shigong Chen
Deputy GM & Director3yrsCN¥1.10m0.12%
CN¥ 5.3m
Yanping Zhao
Independent Director3yrsCN¥170.00kno data
Guotao Ning
Chairman of the Supervisory Board8.5yrsno datano data
Wan Luo
Supervisor8.5yrsno datano data
Xiaofang Xu
Independent Director3yrsCN¥170.00kno data
Binbin Liu
Director3yrsCN¥1.40m0.20%
CN¥ 9.3m
Lei Cao
Independent Director3yrsCN¥170.00kno data
Wang Jun
Supervisor6yrsno datano data

4.5yrs

Average Tenure

51.5yo

Average Age

Experienced Board: 603676's board of directors are considered experienced (4.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:20
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tibet Weixinkang Medicine Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiaxi XuIndustrial Securities Co. Ltd.